Literature DB >> 19879805

Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis.

S A Sharpe1, E Eschelbach, R J Basaraba, F Gleeson, G A Hall, A McIntyre, A Williams, S L Kraft, S Clark, K Gooch, G Hatch, I M Orme, P D Marsh, M J Dennis.   

Abstract

Sensitive and reproducible methods are needed to measure the impact on the host following experimental challenge with Mycobacterium tuberculosis, in order to determine the degree of protection conferred by new vaccines. Here we compare how well different clinical and post-mortem measures of disease burden predict the response by the host to increasing doses of M. tuberculosis in rhesus and cynomolgus macaques. The total lung and lesion volume was quantified from magnetic resonance imaging (MRI) digital stacks obtained from lungs of M. tuberculosis infected animals that were formalin fixed and scanned ex-vivo. The total lung lesion volume relative to the fixed whole lung volume was superior at indicating disease burden when compared to thoracic radiography, pathology scores, changes in body weight and temperature, as well as erythrocyte haemoglobin concentrations and sedimentation rate. The total lesion volume accurately reflected differences in challenge doses of M. tuberculosis that ranged from 30 to 500 CFU delivered by aerosol. The determination of total lesion volume from MR images demonstrated a species-dependent difference between rhesus and cynomolgus macaques in susceptibility to M. tuberculosis infection. MR stereology provides an accurate, quantifiable and relatively simple assessment, which can be easily standardized between laboratories and should form an essential component of the clinical assessment of disease progression, or vaccine efficacy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879805     DOI: 10.1016/j.tube.2009.09.002

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  34 in total

1.  Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing.

Authors:  S A Sharpe; H McShane; M J Dennis; R J Basaraba; F Gleeson; G Hall; A McIntyre; K Gooch; S Clark; N E R Beveridge; E Nuth; A White; A Marriott; S Dowall; A V S Hill; A Williams; P D Marsh
Journal:  Clin Vaccine Immunol       Date:  2010-06-09

2.  Experimental model of tuberculosis in the domestic goat after endobronchial infection with Mycobacterium caprae.

Authors:  Bernat de Val Pérez; Sergio López-Soria; Miquel Nofrarías; Maite Martín; H Martin Vordermeier; Bernardo Villarreal-Ramos; Nadine Romera; Manel Escobar; David Solanes; Pere-Joan Cardona; Mariano Domingo
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

3.  Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.

Authors:  Patricia A Darrah; Diane L Bolton; Andrew A Lackner; Deepak Kaushal; Pyone Pyone Aye; Smriti Mehra; James L Blanchard; Peter J Didier; Chad J Roy; Srinivas S Rao; David A Hokey; Charles A Scanga; Donata R Sizemore; Jerald C Sadoff; Mario Roederer; Robert A Seder
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

Review 4.  Tuberculosis vaccine types and timings.

Authors:  Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2014-12-24

Review 5.  The non-human primate model of tuberculosis.

Authors:  D Kaushal; S Mehra; P J Didier; A A Lackner
Journal:  J Med Primatol       Date:  2012-03-20       Impact factor: 0.667

6.  Toward Tuberculosis Vaccine Development: Recommendations for Nonhuman Primate Study Design.

Authors:  Dominick J Laddy; Aurelio Bonavia; Willem A Hanekom; Deepak Kaushal; Ann Williams; Mario Roederer; Robert A Seder; Sally Sharpe; Frank A W Verreck; Patricia A Darrah
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

7.  Rhesus Macaques Are More Susceptible to Progressive Tuberculosis than Cynomolgus Macaques: a Quantitative Comparison.

Authors:  Philana Ling Lin; Charles A Scanga; JoAnne L Flynn; Pauline Maiello; Robert M DiFazio; Anthony M Cadena; Mark A Rodgers
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

Review 8.  Understanding latent tuberculosis: a moving target.

Authors:  Philana Ling Lin; Joanne L Flynn
Journal:  J Immunol       Date:  2010-07-01       Impact factor: 5.422

9.  Stereological analysis of bacterial load and lung lesions in nonhuman primates (rhesus macaques) experimentally infected with Mycobacterium tuberculosis.

Authors:  Paul A Luciw; Karen L Oslund; Xiao-Wei Yang; Lourdes Adamson; Resmi Ravindran; Don R Canfield; Ross Tarara; Linda Hirst; Miles Christensen; Nicholas W Lerche; Heather Offenstein; David Lewinsohn; Frank Ventimiglia; Laurie Brignolo; Erik R Wisner; Dallas M Hyde
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-08-26       Impact factor: 5.464

Review 10.  Modeling tuberculosis in nonhuman primates.

Authors:  Charles A Scanga; JoAnne L Flynn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-11       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.